TABLE 2.

HLA-DR and -DQ in type 1 diabetic responders and nonresponders

	n	DR3	DR4	DR3/DR4	DQ2	DQ3
Nonresponders	22	41	59	14	41	64
Responders	20	50	95 (P = 0.01)	45 (P = 0.04)	50 (P = 0.75)	95 (P = 0.02)

Data are % unless otherwise indicated. T-cell proliferation (CDI) to WP was evaluated in type 1 diabetic patients. Patients with a CDI value greater than mean + 3 SD of the control group (CDI >14.6) were classified as responders. Those below were classified as nonresponders. The percentage of individuals with the indicated HLA haplotypes in these groups was calculated.